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Highlights 10 
- PLA nanoparticles loaded with Thymol were prepared for the first time.  11 
- The PLA was found to be the key variable in optimizing the nanoparticle preparation. 12 
- The nanoparticles exhibited a high storage stability over a wide range of pHs.  13 
- The antimicrobial activity of the nanoparticles was tested on apple pieces.  14 
Abstract 15 
Thymol is widely recognised as an antibacterial compound. However, its use in food technology 16 
is hindered by its high volatility, its light sensitivity and its low solubility in water. To overcome 17 
these drawbacks, the preparation of nanoparticles using polylactic acid (PLA) is proposed in this 18 
study.   19 
The average size of the nanoparticles and thymol encapsulation efficiency parameters were 20 
studied using different PLA and thymol concentrations. Furthermore, the morphology, the 21 
storage stability of the nanoparticles at several pHs and the in vitro thymol release profile were 22 
also studied, as well as their thermal degradation profile. Finally, their antimicrobial activity on 23 
a real food model was measured, using for this purpose apple pieces previously inoculated with 24 
E. coli. 25 
The PLA was found to be the key variable in optimizing the nanoparticle preparation, producing 26 
spherical nanoparticles with a thymol encapsulation efficiency of 60.3 ± 8%.  These nanoparticles 27 
showed a high storage stability at several pHs and improved antimicrobial properties in 28 
comparison with the non-encapsulated thymol. 29 
Keywords 30 
PLA; thymol; encapsulation; nanoparticles; antimicrobial properties; storage stability; thermal 31 
degradation; release profile. 32 
 33 
1. Introduction 34 
 35 
The aromatic and medicinal properties of the plants of the genus Thymus have been widely 36 
recognized. These plants are usually used to make tea, as a flavouring agent and for medicinal 37 
purposes (Stahl-Biskup and Sáez, 2003).The results reported reveal that the main constituent 38 
obtained from the aerial parts of the plant are geraniol, linalool, gamma-terpineol, carvacrol and 39 
thymol (Piccaglia et al., 1993). Thymol (2-isopropyl-5-methylphenol) is a volatile compound 40 
which is a phenolic derivate of the terpene 3-hidroxy-p-cymene and its production by the plant 41 
is associated with part of its defensive strategy against phytopathogenic microorganisms. 42 
Numerous studies have reported the antibacterial and fungicidal properties of thymol (Andrade-43 
Ochoa et al., 2015; Džamić et al., 2015; Hernández-Hernández et al., 2014). For this reason, this 44 
compound has received the attention of the food industry, thymol having been used as an 45 
antimicrobial agent and authorized by the Food and Drugs Administration (FDA) of the USA as 46 
generally recognised as safe (GRAS). However, there are technical limitations which hinder its 47 
use, such as the high volatility of thymol at room temperature, its high light sensibility and its 48 
low solubility in water  (Mastelić et al., 2004). 49 
One way to overcome these problems is the preparation of nanoparticles which contain thymol. 50 
In the form of nanoparticles, the amount of thymol introduced into the food matrix could be 51 
increased above its solubility limit, since the Brownian movement of the nanoparticles prevents 52 
their sedimentation in the lower layers of the food (Huang, 2012). Furthermore, the high 53 
surface-area ratio of nanoparticles enhances their contact with the microorganisms, and the 54 
protective environment provided could limit the volatility of the thymol and its light-induced 55 
degradation. For this reason, several authors have prepared protein-based nanoparticles which 56 
incorporate thymol. To prepare these nanoparticles, the main protein used was zein, since both 57 
zein and thymol are soluble in ethanol and the particles can be prepared by antisolvent 58 
precipitation (Rosa et al. (2015), Li et al. (2012), Zhang et al. (2014) and Chen et al. (2015)). 59 
However, the use of biodegradable synthetic polymers instead of proteins to encapsulate 60 
thymol remains unstudied, although their use to prepare nanoparticles is a topic that has 61 
received a lot of attention from the scientific community. These synthetic polymers have some 62 
advantages with respect to proteins: they are produced with a high level of purity, the 63 
experiments investigating their use have excellent reproducibility and they do not produce any 64 
antigenic effect (Nair and Laurencin, 2005). In particular, polylactic acid (PLA) has been widely 65 
used in biomedicine and it is considered a good material to prepare micro and nanoparticles, 66 
since the particle size and shape can be controlled so as to satisfy the preparation requirements.  67 
Furthermore, in this type of nanoparticle, the active agent is usually homogeneously dispersed 68 
within the PLA matrix, which is positively related to the appropriate liberation of the active agent 69 
(Lee et al., 2016).  70 
To the best of our knowledge, this study documents the first preparation of PLA nanoparticles 71 
containing thymol. The production of these nanoparticles was evaluated using different PLA and 72 
thymol concentrations, and then they were characterised by evaluating their morphology, 73 
encapsulation efficiency, stability at several pHs and thermal degradation profile. The 74 
antimicrobial properties of the nanoparticles obtained were tested on apple pieces previously 75 
inoculated with E. coli.  76 
 77 
2.  Materials and methods 78 
2.1. Materials 79 
The PLA (180 kDa) was produced by NatureWorks (4032D). The following reagents were 80 
acquired in Sigma-Aldrich (St Louis, USA): thymol (ref. T0501), dichloromethane (DCM, ref 81 
270997), polyvinyl alcohol (PVA, ref P8136), buffer Trizma® pH 7.0 (ref. T1819), 2,2-diphenyl-1-82 
picrylhydrazyl (DPPH, ref. D9132) and Nutrient Broth (NB, ref. 70149NB). The agar was acquired 83 
in VWR (Pensilvania, USA).  84 
2.2. Preparation of PLA nanoparticles  85 
Nanoparticles were prepared following the single emulsion preparation technique (Lee et al., 86 
2016) with slight modifications: a 1% PVA  solution was prepared and saturated with thymol.  In 87 
order to prepare this solution, the PVA at the required concentration was heated in a water bath 88 
at 90 °C until it was completely dissolved. This solution was cooled to room temperature, 2 89 
mg/mL of thymol was added and the mixture was stirred overnight. Then, the solution was 90 
filtered to remove the non-solubilised thymol using a vacuum pump and Nº1 Whatman paper. 91 
The filtration process was repeated twice. 92 
Three different amounts of PLA were dissolved in 7.5 mL of DCM, and for each of these PLA 93 
concentrations, three different amounts of thymol were dissolved in the same DCM volume. 94 
These percentages of thymol with respect to the weight of PLA, as well as the precise amounts 95 
of thymol and PLA tested in each case are shown in Table 1.   96 
Table 1. Amounts of PLA and thymol dissolved in the organic phase and tested to optimize the 97 
nanoparticle preparation.  98 
 Thymol 
PLA 66% 100% 133% 
100 mg 66 mg 100 mg 133 mg 
150 mg 100 mg 150 mg 200 mg 
200 mg 133 mg 200 mg 266 mg 
 99 
This DCM solution was carefully poured into 30 mL of the previously prepared PVA solution. The 100 
mixture was ultrasonicated for 2.5 minutes using the Sonopuls HD 2070 system (Bandelin, 101 
Germany) and the MS 73 probe, at a frequency of 20 kHz and applying a sonication amplitude 102 
of 90% (100% corresponds to 212 µm). This sonication amplitude corresponds to an ultrasonic 103 
intensity of 80 W/cm2. During the sonication process, the sample was kept in ice to avoid 104 
temperature increase. To remove the DCM contained in the preparation, the emulsified solution 105 
was kept in a low-pressure medium at 40 °C for 40 minutes using a rotavapor (Büchi R-205, Büchi 106 
Labortechnik, Essen, Alemania). During the DCM evaporation, part of the thymol was able to 107 
pass from the nanoparticles to the PVA medium. It was precisely to avert this problem that the 108 
PVA solution was saturated with thymol, as was described previously.  109 
After the DCM evaporation, the sample was centrifuged at 13000 rpm for 20 minutes to 110 
precipitate the nanoparticles. The supernatant, which contains the PVA and is saturated with 111 
thymol, was removed by decantation and it could be reused to prepare new nanoparticles.  The 112 
same volume of distilled water was added to the sediment, and the nanoparticles were 113 
resuspended and centrifuged again at 4000 rpm for 5 minutes. In this case, the sediment was 114 
discarded to remove PLA aggregates, the nanoparticles remaining in suspension.  115 
2.3. Nanoparticle size measurement and thymol content 116 
The average size of the nanoparticles and their polydispersion index (PDI) were measured using 117 
dynamic light scattering (DLS, Nanosizer ZS, Malvern, UK).  118 
The amount of thymol encapsulated was measured as follows: the nanoparticle suspension was 119 
centrifuged at 13000 rpm for 20 minutes and the supernatant was removed and replaced with 120 
the same volume of ethanol (96°). The sediment, which contains the nanoparticles, was 121 
dispersed in the ethanol with the aid of the sonicator system. Then, the sample was centrifuged 122 
again at 13000 rpm for 20 minutes. During this process and due to the high solubility of thymol 123 
in ethanol, the active agent was extracted from the nanoparticles. Finally, 0.1 mL of this 124 
ethanolic solution was diluted with 9.9 mL of fresh ethanol. The absorbance of the resulting 125 
solution was measured at 275 nm using a spectrophotometer (Spekol 1500, Analytik Jena AG, 126 
Jena, Alemania). Previously, known concentrations of thymol in ethanol were measured at this 127 
wavelength to calculate a calibration curve. The encapsulation efficiency (EE%) was calculated 128 
according to the following equation. 129 
                      EE% =
thymol encapsulated
thymol added in the DCM solution
× 100                                 (1) 130 
 131 
2.4. Nanoparticle morphology 132 
 A drop of the nanoparticle solution was placed on a copper grid and negatively stained with a 133 
drop of phosphotungstic acid solution 2% (w/v). The micrographs were obtained using a 134 
transmission electron microscope (TEM, JEOL-2000 EX-II, Tokyo, Japan) operated at 200 kV. 135 
Furthermore, micrographs obtained using a scanning electron microscopy (SEM, JSM-6610LV, 136 
JEOL, USA) were also performed. In this case, a drop of the sample was dried on a glass 137 
microscope slide and coated with gold. The surface morphology of the nanoparticles was 138 
observed at 20 kV. 139 
2.5. Nanoparticle storage stability at various pHs 140 
A freshly prepared solution of nanoparticles was centrifuged at 13000 rpm for 20 minutes and 141 
the supernatant was discarded. The sediment, which contains the nanoparticles, was 142 
resuspended in a buffer solution at pH 4.0 (phosphate-citrate), or at pH 7.0 (Trizma®), or at pH 143 
9.0 (sodium carbonate-bicarbonate) and stored at 5 °C. The buffer concentration was 0.01 M in 144 
all cases. Periodically, the average size of the nanoparticles and the thymol content were 145 
measured.  146 
 147 
2.6. Thermogravimetric analysis (TGA) 148 
The samples tested were lyophilized for 24 hours whilst applying a pressure of 0.33 mbar. The 149 
TGA curves were carried out in an SDTA851e TGA analyser (Mettler-Toledo, Switzerland) from 150 
30 °C to 700 °C, under a nitrogen atmosphere. The heating rate was 10 °C/min. In this case, four 151 
samples were tested: the nanoparticles loaded with thymol; the nanoparticles prepared as 152 
described in section 3.2, but without the addition of thymol (unloaded nanoparticles); the 153 
thymol and the PLA. 154 
2.7. In vitro thymol release profile 155 
To evaluate the thymol release profile, 10 mL of a freshly prepared solution of nanoparticles was 156 
placed in a dialysis tube of 10 kDa MWCO, which was placed in a thermostatically controlled, 15 157 
L capacity water bath (ref. 3001373, J. P. Selecta, Barcelona, Spain). The water in the bath was 158 
under agitation due to a water stream provided by a pump. Several temperatures were tested, 159 
and periodically one aliquot of 0.5 mL was taken from the dialysis tube and the thymol content 160 
in the nanoparticles measured. To characterise the thymol release profile, the data obtained 161 
were modelled using a first order equation (eq. 2) and  the Korsmeyer-Peppas equation (eq. 3) 162 
(Siepmann and Peppas, 2001). 163 
 164 
                
Mt
M∞
= 1 − e−kt                                                                                     (2) 165 
                
Mt
M∞
= k ×  tn                                                                                       (3) 166 
 167 
Where  
𝑀𝑡
𝑀∞
 is the accumulated percentage of thymol released at each time (t), k is the release 168 
constant of thymol and n is the diffusion exponent that characterises the release mechanism of 169 
the thymol. 170 
 171 
 172 
2.8. Nanoparticle antimicrobial properties 173 
 174 
To compare the antimicrobial properties of thymol and the nanoparticles loaded with thymol, 175 
apple pieces weighing 1 g were inoculated with the non-pathogenic E. coli CECT 101 strain. This 176 
strain was incubated at 30 °C for 48 hours using NB medium supplemented with 2% agar. To 177 
prepare the liquid inoculum, E. coli was incubated in NB liquid medium for 10 hours, at 30 °C 178 
with orbital stirring (250 rpm).  179 
For all these treatments, each piece of apple was inoculated with 100 µL of E. coli and left for 2 180 
minutes. The E. coli concentration used for this experiment was 105 UFC/mL, which might be 181 
considered high, but the strong antimicrobial properties of thymol made it necessary so as to be 182 
able to detect variation in the ability to decrease E. coli growth on the apple pieces between 183 
different preparations. After the inoculation, the apple pieces were submerged for 1.5 minutes 184 
in 5 mL of an aqueous solution that contained thymol or nanoparticles loaded with thymol. To 185 
solubilise the thymol, crystals of this active agent were added to distilled water at a 186 
concentration of 2 mg/mL, stirred overnight and filtered using nº1 Whatman paper. The 187 
concentration of dissolved thymol was determined by mixing 0.1 mL of this filtered solution with 188 
9.9 mL of ethanol and measuring the absorbance at 275 nm, in accordance with the 189 
methodology described in section 2.3. To investigate the antimicrobial effect of this solution, 190 
three thymol concentrations were tested: 0.94 mg/mL, which corresponds to the maximum 191 
concentration of thymol dissolved in water, 0.5 mg/mL and 0.1 mg/mL. The same concentrations 192 
of thymol were used for the nanoparticle samples. After the treatment, the apple pieces were 193 
hermetically closed in polyethylene boxes and stored at 5 °C until their analysis. To follow the 194 
growth of the E. coli on the apple surface, samples were taken at different times and mixed with 195 
9 mL of NaCl 0.7%. Then, the samples were homogenised using a stomacher and cultured in NB-196 
agar medium. After 24 hours of incubation at 30 °C the E. coli colonies were counted and the 197 
results obtained expressed as log10 UFC/g.  198 
2.9. Statistical analysis 199 
Experiments were performed in triplicate and are shown as the mean value ± standard deviation 200 
of three independent experiments (n = 3). Least significant differences (LSD) were calculated by 201 
Fisher’s test to determine significant differences between the tested samples. These analyses 202 
were performed using the statistical software Statgraphics® V.15.2.06. 203 
 204 
3. Results 205 
3.1. Size, polydispersity index, thymol recovered and encapsulation efficacy of the 206 
nanoparticles prepared 207 
There are several parameters that could have a significant effect on the preparation of these 208 
nanoparticles and have the capacity to modify their average size and the efficiency with which 209 
they encapsulate thymol. In this sense, the variables which should be considered would include 210 
the amount of DCM and water, the time and type of stirring used to obtain the emulsion 211 
(ultrasounds or mechanical stirring), the amount of energy applied during the process, the type 212 
and concentration of surfactant used to stabilise the emulsion, and the amounts of PLA and of 213 
thymol.  In our previous tests it was observed that, among all these parameters, variations in 214 
the PLA and thymol concentrations produced changes in the properties of the nanoparticles in 215 
a meaningful and straightforward way, and for this reason they were considered to be key 216 
variables for this process.   217 
Figure 1A indicates the average size of the prepared nanoparticles and their PDI, whilst in Figure 218 
1B the amount of thymol encapsulated and the encapsulation efficiency are shown. According 219 
to Figure 1A, these values suggest that, in broad terms, the higher the concentration of PLA in 220 
the organic phase, the greater is the average size of the nanoparticles obtained. A similar trend 221 
was observed when the amount of PLA was kept constant and the concentration of thymol was 222 
increased. The latter effect was particularly pronounced in the 200 mg PLA samples. 223 
Furthermore, in all cases the PDI values obtained were low enough to be considered satisfactory, 224 
being even lower than those obtained by other authors in the preparation of similar PLA 225 
nanoparticles (Roussaki et al., 2014; Wrona et al., 2017). As regards Figure 1B, the thymol 226 
recovered from the nanoparticles followed a similar trend to the average size, in that increasing 227 
the concentration of PLA and thymol led to an increase in the amount of thymol recovered. 228 
However, the encapsulation efficiency showed a different trend to the recovered thymol 229 
parameter, and the highest values obtained were from the 150 mg PLA preparations. In this 230 
case, the 100 mg PLA preparations showed the lowest encapsulation efficiency values, probably 231 
because the amount of PLA was low enough to produce nanoparticles with low internal density 232 
and high porosity, which were incapable of retaining the thymol. In the case of the 200 mg PLA 233 
nanoparticles, the density effect may have been reversed, and so, due to their high density, most 234 
of the nanoparticles could have precipitated out by the end of the last centrifugation (5000 rpm, 235 
4 min.), which was carried out in accordance with the preparation methodology described in the 236 
materials and method section. 237 
Taking into account all these results, and although the concentration of thymol and PLA 238 
produced variations in the size of the nanoparticles, in all the tested preparations this parameter 239 
was maintained within the 220 - 260 nm range. Since this could be considered a narrow range, 240 
it might be more effective to optimize the encapsulation efficiency in order to prevent loss of 241 
reagent and to increase the amount of thymol recovered. From the results shown in Figure 1B, 242 
the best preparation was seen to be that obtained using PLA and thymol concentrations of 150 243 
mg. Furthermore, the PLA concentration resulted more relevant than the thymol concentration 244 
to maximize the efficacy of encapsulation parameter. 245 
 246 
       247 
Figure 1. Parameters of interest for the characterisation of the nanoparticle preparations with 248 
respect to the PLA and thymol concentrations. Dotted bars correspond to the nanoparticles 249 
prepared using 100 mg de PLA, striped bars 150 mg of PLA and solid bars 200 mg of PLA. A: 250 
Average size (bars) and polydispersity index (line) of the nanoparticles prepared. B: Thymol 251 
recovered (bars) and encapsulation efficiency (line) of the nanoparticles prepared. 252 
 253 
3.2. Nanoparticle morphology 254 
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The TEM and SEM micrographs of the nanoparticles prepared with 150 mg of PLA and several 255 
concentrations of thymol are shown in Figure 2. In all the cases, spheres with a smooth surface 256 
were observed. The size of the nanoparticles varied between 240 and 260 nm, corroborating 257 
the values obtained by DLS provided in section 3.1. The morphology of the nanoparticles 258 
prepared using proteins or polysaccharides is not usually so regular, and may have a rougher 259 
appearance, which could have some influence on the release profile of the active agent. 260 
Wattanasatcha et al. (2012) produced nanoparticles of ethylcellulose/methylcellulose loaded 261 
with thymol and with an almost spherical morphology. Similar results were obtained by Xue et 262 
al. (2014) preparing nanodispersions of lecithin, gelatin and thymol.  263 
 264 
 265 
Figure 2. TEM (A, B, C) and SEM (C, D, E) micrographs of the nanoparticles prepared using 150 266 
mg of PLA and 100 mg (A, D), 150 mg (B, E) and 200 mg (C, F) of thymol. 267 
 268 
3.3. Nanoparticle storage stability at several pHs 269 
The storage stability of the nanoparticles was tested at several pHs. For this purpose, the 270 
average size and the thymol encapsulated were evaluated every 10 days for 40 days. The results 271 
obtained are shown in Table 2. In all the tested samples, during a period of 40 days no changes 272 
were detected in the size of the nanoparticles at any pH. As regards the thymol encapsulated, 273 
at basic pH a slight decrease in this parameter was detected. In the case of the nanoparticles 274 
stored at pH 7.0 and 4.0, this decrease was even less pronounced. This could be due to the 275 
deprotonation of the phenolic hydroxyl group of the thymol at basic pH (Wu et al., 2012), which 276 
would increase its solubility in water, therefore enhancing the movement of the active agent 277 
from the nanoparticle to the aqueous medium. In any case, the decrease detected in the thymol 278 
loaded within the nanoparticles in 40 days can be considered low at all the pHs tested. Finally, 279 
it should be remembered that the encapsulation of thymol in protein-based nanoparticles is 280 
usually pH-dependent, since the proteins tend to aggregate or solubilize at a specific range of 281 
pH.  In this case, the PLA nanoparticles do not exhibit this inconvenience and can be used over 282 
a wide range of pHs.  283 
 284 
 Table 2. Storage stability of the nanoparticles loaded with thymol at several pHs for 40 days.  285 
 Average size (nm) Thymol encapsulated (%) 
 Day 1 Day 10 Day 20 Day 30 Day 40 Day 1 Day 10 Day 20 Day 30 Day 40 
pH 4.0 241.3 ± 
1.3a 
242.7 ± 
2.7a 
240.15 ± 
0.2a 
239.1 ± 
2.2a 
238.0 ± 
2.5a 
100a 95.8 ± 
0.6b 
96.4 ± 
0.6b 
96.0 ± 
1.0b 
96.5 ± 
1.0b 
pH 7.0 238.7 ± 
1.3a 
241.0 ± 
0.5a 
238.9 ± 
1.8a 
238.1 ± 
1.5a 
239.5 ± 
1.2a 
100a 98.2 ± 
0.7b 
98.9 ± 
0.8b 
98.0 ± 
1.2b 
97.3 ± 
0.6b 
pH 9.0 238.6 ± 
0.1a 
240.8 ± 
1.5a 
238.8 ± 
1.8a 
240.4 ± 
2.0a 
239.0 ± 
1.0a 
100a 96.7 ± 
0.8b 
95.5 ± 
1.3b 
96.2 ± 
0.9b 
92.2 ± 
1.4c 
Different letters in the same row indicate significant differences (P<0.05).  286 
 287 
3.4. TGA analysis  288 
The TGA analysis of the lyophilized nanoparticles prepared using 150 mg of PLA and the same 289 
amount of thymol, the nanoparticles control without thymol, the reactive thymol and the PLA 290 
are shown in Figure 3A. The derivative of the TGA curves (DTG) obtained are shown in Figure 3B. 291 
In these Figures it can be observed that the pure thymol is degraded completely in one single 292 
stage and over the temperature range 65-190 °C, showing a maximum rate of degradation at 293 
158 °C. The PLA was degraded in a similar way as the thymol but at temperatures between 280 294 
and 370 °C. The nanoparticles control, without thymol, showed a degradation curve similar to 295 
that found for the pure PLA, but divided into two stages. The first of them corresponds to PLA 296 
degradation, from 280 °C to 370 °C and the second one, from 390 °C to 470 °C, corresponds to 297 
PVA degradation (Yu et al., 2003). The degradation of the nanoparticles loaded with thymol was 298 
produced in three stages (Figure 3B). While the second and third stages are similar to those 299 
found for the control nanoparticles, the first stage could be attributed to the degradation of 300 
thymol, but it is offset to the right in comparison with that found for the pure thymol. In fact, 301 
this first degradation stage takes place from 120 °C to 250 °C, with a maximum degradation rate 302 
at 182 °C. This increase in the temperature of degradation of the encapsulated thymol could 303 
occur due to its inclusion in the nanoparticles, which provide a protective environment. 304 
Furthermore, it is significant that the amount of thymol in these nanoparticles is only around 305 
10% of the weight of the lyophilized nanoparticles. This decrease in the thymol content could 306 
be due to the evaporation of thymol during the lyophilization process, since this active agent is 307 
a highly volatile essential oil and the drying process involves the application of low pressures for 308 
a relatively long time.  309 
  310 
Figure 3. TGA (A) and DTG (B) curves of the nanoparticles loaded with thymol, the nanoparticles 311 
control without thymol, the reactive thymol and the PLA. 312 
3.5. In vitro thymol release profile 313 
The thymol release profiles of the loaded (150 mg of PLA and of thymol) nanoparticles at 314 
different temperatures were determined and are shown in Figure 4. Although this type of 315 
experiment has been designed principally to investigate the behaviour of injectable 316 
encapsulated drugs in the bloodstream, it can also provide valuable information about the state 317 
of the active agent inside the nanoparticle matrix and could provide evidence about possible 318 
interactions between the nanoparticle polymers and the active agent. According to this Figure, 319 
the thymol diffuses rapidly from the nanoparticles into the aqueous medium at 35 °C, releasing 320 
93% of the active agent in 6 h. In the same time, if the temperature is lowered to 22 °C, 80% of 321 
the thymol is released. However, at 15 and 5 °C, the release of thymol over 6 hours decreases 322 
to 60%. As was to be expected, the rate of thymol release is temperature-dependent. Both at 323 
35 and 22 °C the release of thymol for the first 2 hours is fast, and then a slight decrease in this 324 
release rate was detected. This first burst effect in 2 hours could be due to the release of the 325 
thymol adhered to the surface of the nanoparticles and to the thymol that is within the 326 
nanoparticles, but in the more external layers  (Yadav and Sawant, 2010). The geometry of the 327 
nanoparticles and their high surface/volume ratio could be the reason for this first fast release. 328 
From this point, the thymol released came from the inner layers of the nanoparticles.  329 
Furthermore, during the first hour at 15 and 5 °C there is a slight delay in the thymol release. 330 
This slow release could be due to the presence of free thymol remaining in the solution 331 
containing the nanoparticles. At the beginning of the test this thymol would be in the process of 332 
diffusing out of the dialysis tube, whereas at the highest temperatures tested, the thymol 333 
cleared quickly from the dialysis tube. Once the thymol excess disappears from the dialysis tube, 334 
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the active agent is released quickly between the first and the fourth hour, in the case of the 15 335 
°C experiment, and between the first and third hour when the temperature is lowered to 5 °C. 336 
Then, the thymol in the inner layers of the nanoparticles is also released, but at a lower speed. 337 
In any case, and bearing in mind that the antimicrobial and antioxidant properties of the thymol 338 
are concentration-dependent, this initial burst effect is desirable, since it allows an initial 339 
increase in the amount of free thymol in the medium.  340 
There are several empirical models that can easily be applied to release profiles similar to those 341 
shown in Figure 4 and that have been widely reported in bibliography. In this case, the 342 
Korsmeyer-Peppas model was used, and the results obtained are shown in Table 3. To apply this 343 
model, only the data from the release curve up to 60% thymol release were considered 344 
(Siepmann and Peppas, 2012). Furthermore, neither the first hour in the experiments at 35 and 345 
22 °C, nor the first two hours in those at 15 and 5 °C were considered. This omission was due to 346 
the distortion produced in the model by the burst effect at the two highest temperatures tested, 347 
and the delay detected in the thymol release at the two lowest temperatures. In this model, the 348 
value of the exponent “n” could be used to interpret, to some extent, the process of the 349 
mobilization of the thymol from the interior of the nanoparticle to the aqueous medium. Thus, 350 
if “n” is equal to 0.43, the diffusion of the active agent follows Fick’s law. On the other hand, if 351 
the “n” value varies between 0.43 and 0.85, then the transport mechanism is catalogued as 352 
anomalous, being a mixture of Fickian diffusion and the movement of thymol produced by 353 
swelling of the nanoparticle.  If alternatively, the value of “n” is equal to 0.85, then the transport 354 
is caused mainly by the nanoparticle swelling (Ritger and Peppas, 1987). Bearing this in mind 355 
and referring to Table 3, in all the cases in this experiment the mechanism of transport is 356 
anomalous, except at 5 °C, where due to the decrease in the temperature, the diffusion 357 
mechanism was hindered and the transport produced by the nanoparticle swelling becoming 358 
more important.  359 
In Table 3 are also shown the first order kinetic equation parameters obtained from the 360 
experimental data. These results showed that in all the cases the thymol release can be adjusted 361 
to this type of kinetic with a high coefficient of determination (R2), which suggests that this 362 
release is dependent on the thymol concentration. Furthermore, and as was expected, the “k” 363 
value decreased when the temperature also decreased, showing that the release of this active 364 
agent at low temperatures is slower in comparison with the same release at high temperatures. 365 
 366 
 367 
Figure 4. Thymol release from the nanoparticles prepared using 150 mg of PLA and 150 mg of 368 
thymol at 35 °C (circles), 22 °C (triangles), 15 °C (rhombi), and at 5 °C (squares). 369 
 370 
 371 
Table 3. Parameters of interest obtained from Figure 4. 372 
 First order Korsmeyer-Peppas 
 R2 k R2 n 
35 °C 0.94 0.40 0.99 0.77 
22 °C 0.98 0.28 0.99 0.67 
15 °C 0.97 0.17 0.99 0.60 
5 °C 0.97 0.14 0.98 0.85 
 373 
 374 
 375 
 376 
3.6. antimicrobial properties of the nanoparticles 377 
In Figure 5 is shown the effect of the aqueous solution with free thymol and the thymol 378 
encapsulated in nanoparticles on E. coli growth. In the samples treated with free and 379 
encapsulated thymol at 0.94 mg/mL, it was not to possible detect E. coli growth during the 14 380 
days of treatment, so the thymol at this concentration was able to kill all the bacterial population 381 
inoculated. On the other hand, the solutions with a thymol concentration of 0.1 mg/mL showed 382 
0
20
40
60
80
100
120
0 2 4 6 8 10 12 14 16 18 20 22 24 26
M
t 
/ 
M
∞
 (
%
)
Time (hours)
a behaviour similar to that found in the control sample, it being impossible to detect differences 383 
between the encapsulated and non-encapsulated thymol. Therefore, the lowest thymol 384 
concentration tested did not have any effect on the growth of E. coli. However, in the samples 385 
treated with 0.5 mg/mL of thymol it was possible to detect a difference between the 386 
nanoparticles and the free thymol. While the free thymol was seen to be more effective than 387 
the nanoparticles in the initial days of the experiment, the encapsulated thymol produced a 388 
continuous decrease in E. coli growth during the 14 days of the experiment, proving to be more 389 
effective than the free thymol in the long-term. This could be due to the nanoparticles providing 390 
an environment that protects the thymol from evaporation, maintaining its effect for longer. 391 
 The superficial application of the nanoparticles loaded with thymol on the surface of a solid 392 
food could be a more realistic use for them than the typical applications found in the 393 
bibliography, which are mainly focused on the antibacterial properties of nanoparticles in liquid 394 
foods (Chen et al., 2014; Chen et al., 2015; Pan et al., 2014; Shah et al., 2012). Although from a 395 
scientific point of view, the use of liquid food to study the antibacterial properties of thymol-396 
loaded nanoparticles is very interesting, in a practical way it requires a homogeneous dispersion 397 
of the thymol throughout the volume of the liquid, and in this case the flavour of the thymol 398 
could affect the organoleptic properties of the product, even though this active agent is 399 
encapsulated. However, the use of these nanoparticles to protect the surface of solid food 400 
requires only its immersion in a nanoparticle suspension, which limits the contact of the product 401 
with the active agent while the nanoparticles maintain their capacity to protect the thymol and 402 
release it over time.     403 
 404 
Figure 5. Growth of E. coli CECT 101 on apples treated with solutions containing free thymol 405 
and nanoparticles loaded with thymol. 406 
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 407 
4. Conclusions 408 
In the tests performed using different PLA and thymol concentrations, the amount of PLA was 409 
found to be a key parameter to optimize the preparation of the thymol-loaded nanoparticles. 410 
These nanoparticles exhibited a spherical morphology, with a smooth surface and high storage 411 
stability over a wide range of pHs. Precisely, this stability at acidic and basic pHs could be 412 
considered an advantage in favour of these PLA nanoparticles when compared to those 413 
prepared using proteins and/or carbohydrates. Furthermore, their regular morphology and the 414 
homogenous arrangement of the active agent in the core are other relevant features that other 415 
biopolymer-based nanoparticles lack, and that have an important effect on the way the 416 
nanoparticles release the active agent. However, as can be seen from the TGA curves of the 417 
lyophilized PLA nanoparticles shown previously, a large proportion of the thymol evaporated 418 
during the lyophilization process, although this inconvenience could be compensated by the 419 
great stability of the nanoparticles in an aqueous suspension. Finally, using apple pieces 420 
inoculated with E. coli as a real food model, the PLA nanoparticles showed the capacity to 421 
maintain the thymol activity for 14 days, probably limiting its evaporation from the wet surface 422 
of the apple and favouring its release over time. The use of thymol-loaded nanoparticles to 423 
protect the surface of solid foods could be a more realistic use for them than their incorporation 424 
in liquid foods, since the first use limits the amount of thymol necessary to produce its 425 
antibacterial effect, minimising the strong flavour of the thymol.  426 
 427 
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